EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion
Auxier Asset Management Cuts Position in Pfizer Inc. (NYSE:PFE)
Formidable Asset Management LLC Sells 507 Shares of Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (PFE) Delivers Oncology Milestones with MesoC2 Debut and XTANDI Survival Boost
Pfizer Inc. (NYSE:PFE) Shares Sold by Public Employees Retirement System of Ohio
Pfizer Inc. (NYSE:PFE) Shares Purchased by Sunbelt Securities Inc.
Novem Group Takes Position in Pfizer Inc. (NYSE:PFE)
Concurrent Gainers: 6 stocks gain for 5 days in a row
PFE Stock: Is Pfizer's 7.5% Dividend Too Good to Last?
Pfizer (NYSE:PFE) Stock Price Down 1% - Should You Sell?
Navalign LLC Sells 990 Shares of Pfizer Inc. (NYSE:PFE)
JT Stratford LLC Acquires 7,240 Shares of Pfizer Inc. (NYSE:PFE)
First Heartland Consultants Inc. Sells 1,972 Shares of Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Shares Purchased by Breed s Hill Capital LLC
Waverly Advisors LLC Sells 57,845 Shares of Pfizer Inc. (NYSE:PFE)
FDA may change Covid-19 booster rules from 2025: What it means for you
Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting | The Manila Times
Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting - PR Newswire APAC
Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting | Morningstar
Cell and Gene Therapies in Rare Disorders Market on Track for Major Expansion by 2034, According to DelveInsight | Pfizer, Sangamo Therapeutics, Orchard Therapeutics, SR-Tiget, Novartis, TVAX Biomed | ABNewswire
Covid-19 vaccine rules may change from 2025: What you should know
Astellas And Pfizer's XTANDI Shows Long-Term Survival Benefits In Metastatic Prostate Cancer
FDA Panel Recommends Monovalent COVID Vaccine for Next Season | MedPage Today
Astellas Pharma and Pfizer's Xtandi shows long-term survival in prostate cancer | Markets Insider
Was Jim Cramer Right About Pfizer Inc. (PFE)?
FDA: Add Heart Risk to COVID Shot Warning Label | Newsmax.com
COVID Vaccine "Safe and Effective" Narrative Collapses On Camera | ZeroHedge
Pfizer Inc. (NYSE:PFE) Shares Acquired by Harmony Asset Management LLC
Harmony Asset Management LLC Grows Stock Position in Pfizer Inc. (NYSE:PFE)
Trade Spotlight: How should you trade Grindwell Norton, Morepen Labs, Astral, Aditya Birla Capital, Pfizer, Clean Science and others on May 23?
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
Castleark Management LLC Has $79,000 Stock Position in Pfizer Inc. (NYSE:PFE)
Financial Avengers Inc. Acquires 24,642 Shares of Pfizer Inc. (NYSE:PFE)
SK Bioscience prevails over Pfizer in pneumococcal vaccine dispute
Ames National Corp Acquires New Shares in Pfizer Inc. (NYSE:PFE)
Css LLC Il Trims Stock Position in Pfizer Inc. (NYSE:PFE)
Woodline Partners LP Boosts Stake in Pfizer Inc. (NYSE:PFE)
FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation | CNN
Dixon Tech, ICICI Securities & more: Top stocks on broker's radar for May 22 - Times of India
Pfizer Hits FDA Setback in Effort to Boost Prostate Cancer Drug
Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal
Pfizer, GITAM University Empower Rural Women with Employment through Pfizer Autonomous Teams Program
Health officials hid myocarditis risks from COVID vaccines, report alleges | Fox News
FDA expands COVID vaccine warning about heart side effect risk for young males
White Knight Strategic Wealth Advisors LLC Grows Stock Holdings in Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Shares Sold by McIlrath & Eck LLC
Giant U.S. companies are rushing to Europe to borrow money
Biden officials knew about, downplayed COVID-19 vaccine risks, Senate report claims
White Knight Strategic Wealth Advisors LLC Increases Position in Pfizer Inc. (NYSE:PFE)
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine | The Manila Times
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine | Morningstar
Pfizer Inc. (NYSE:PFE) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Giant US companies are rushing to Europe to borrow money
Zimmer Partners LP Makes New Investment in Pfizer Inc. (NYSE:PFE)
iSAM Funds UK Ltd Purchases New Shares in Pfizer Inc. (NYSE:PFE)
SK Bioscience Wins Patent Lawsuit Against Pfizer Over 13-valent Pneumococcal Conjugate Vaccine
SK bioscience wins patent dispute against Pfizer over pneumococcal vaccine
Jubilant Pharmova Share Price Today Up 7%
Centralized lists could improve surgery wait times in Canada, study says | Watch News Videos Online
Health Matters: Doctor discusses measles, ticks, sunscreen and more | Watch News Videos Online
Improved functional assessment in cancer patients using home-based digital technologies
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine | Taiwan News | May. 21, 2025 20:00
Pfizer (NYSE:PFE) Trading 0.4% Higher - Should You Buy?
Pfizer-GITAM to provide rural women jobs through Pfizer Autonomous Teams Programme
Pfizer to hold AGM
FDA advisers recommend COVID boosters for 65 and older, reject broad approval
Pfizer Pacing for 4th Day of Gains
Pfizer inks deal with China's 3SBio | The Manila Times
Pfizer makes a $6 billion run into a new cancer drug race, 6 months after rival | Morningstar
Pfizer bets $6B+ on 3Sbio's bispecific PD-1/VEGF antibody | BioWorld
Trump's MFN model may erode Big pharma's 50% US profits, analysts suggest
Top news of the day: Special Court grants bail to gold smuggling suspects; Ashoka University associate professor sent to judicial custody; SC hears petitions on Waqf Act, and more
Zimmer Partners LP Acquires New Shares in Pfizer Inc. (NYSE:PFE)
Pfizer strikes deal with China's 3SBio to license cancer drug
Lupin Share Price Today Down 3%
Lantern Wealth Advisors LLC Purchases 882 Shares of Pfizer Inc. (NYSE:PFE)
WBI Investments LLC Makes New Investment in Pfizer Inc. (NYSE:PFE)
Pfizer Q4 net profit jumps 85% to ₹331 crore - The Hindu
Stocks Surged: Sensex falls! But these stocks gained over 10% on BSE - The Economic Times
Pfizer Q4 net profit jumps 85% to ₹331 crore; revenue rises 8.3% | Company Results - Business Standard
St. Clair Advisors LLC Acquires Shares of 35,967 Pfizer Inc. (NYSE:PFE)
Pfizer share price rises 13% post Q4 Results, dividend announcement despite stock Market crash: Do you own?
Triglav Skladi D.O.O. Takes Position in Pfizer Inc. (NYSE:PFE)
Two Sigma Advisers LP Sells 7,622,100 Shares of Pfizer Inc. (NYSE:PFE)
Pfizer Q4 results: Net profit jumps 85% to Rs 330.94 crore
Two Sigma Investments LP Reduces Position in Pfizer Inc. (NYSE:PFE)
Volumes jump at Pfizer Ltd counter | Capital Market News - Business Standard
Pfizer gallops after good Q4 outcome | Capital Market News - Business Standard
Board of Pfizer recommends special dividend | Capital Market News - Business Standard
Dividend bonanza alert! This Pharma stock shares jump 11% after Rs 165 per share payout - biggest in 5 years | Zee Business
Pfizer shares jump 11% as profit soars 85% YoY in Q4FY25
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
Stocks Surged: Sensex falls! But these stocks are up over 10% on BSE - The Economic Times
PFIZER news
Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors
Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision
Latest news
Show more
Morning Note: Japan's Core Inflation Spikes; UK Retail Surges; Canada Sales Slow
Morning Note: Nvidia Slams China Chip Ban; Bitcoin Climbs on Trade Peace;
